z-logo
open-access-imgOpen Access
Characteristics of circulating CD 31 + cells from patients with coronary artery disease
Author(s) -
Kim Moo Hyun,
Guo Longzhe,
Kim HanSoo,
Kim SungWhan
Publication year - 2014
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.12370
Subject(s) - coronary artery disease , chemokine , pathogenesis , flow cytometry , chemotaxis , immunology , stable angina , macrophage , microbiology and biotechnology , medicine , inflammation , biology , pathology , receptor , biochemistry , in vitro
Recently, we reported the properties of CD 31‐expressing cells in healthy individuals. However, the characteristics of CD 31‐expressing cells derived from coronary artery disease ( CAD ) patients remain unknown. This study aimed to investigate the relationship between circulating CD 31 + cells and CAD as well as their biological characteristics. Analysis with flow cytometry revealed that CD 31 + cells (C‐ CD 31) from the peripheral blood ( PB ) of CAD patients exhibited low levels of T‐cell marker and high levels of macrophage marker compared with the PB ‐ CD 31 + cells from healthy individuals (H‐ CD 31). In addition, the expression levels of multiple pro‐angiogenic and chemokine genes were significantly down‐regulated in C‐ CD 31. However, inflammatory gene IL ‐1 α was highly up‐regulated in C‐ CD 31. Patients with unstable angina ( UA ) had significantly more CD 31 + cells in the PB than healthy control group ( P  < 0.001). Moreover, there were significant correlations between the number of CD 31 + cells and cardiovascular ( CV ) disease activity ( R  = 0.318, P  = 0.006) and the number of diseased coronaries ( R  = 0.312, P  = 0.005). For the diagnostic category of UA , the area under curve was 0.803 ( P  < 0.001). In conclusion, C‐ CD 31 have impaired angiogenic potential and the number of circulating CD 31 + cells were correlated with CV risk. These findings may contribute to the understanding of the pathogenesis of CAD .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom